Nisar Amin, MD
Internal Medicine · Point Pleasant, WVNPI 1467805648
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 39.2% of the total. Reporting peaked in 2022 at $953 and has fallen 98.1% since, to $18 in 2025.
Across 121 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$823
- Astellas Pharma US Inc$156
- GSK$146
- Lilly USA, LLC$136
- Abbott$108
- Sanofi-aventis U.S. LLC$85
- plus $643 from 22 others
What the payments were for
- Food & beverage$2,097100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $823 |
| Astellas Pharma US Inc | 8 | $156 |
| GSK | 8 | $146 |
| Lilly USA, LLC | 9 | $136 |
| Abbott | 6 | $108 |
| Sanofi-aventis U.S. LLC | 6 | $85 |
| Boehringer Ingelheim | 5 | $68 |
| Merck | 3 | $59 |
| Novartis | 4 | $58 |
| Novo Nordisk | 4 | $50 |
| Amarin Pharma, Inc. | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Bayer | 2 | $33 |
| Medtronic | 1 | $30 |
| Johnson & Johnson | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| AstraZeneca | 2 | $27 |
| Pfizer | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Exact Sciences | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
| Idorsia Pharmaceuticals US Inc | 1 | $12 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
| Amgen | 1 | $11 |
How this compares
$2,097 in reported general payments places this provider in the 80th percentile of 573 internal medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 11 | $494 |
| Levothyroxine Sodium | 18 | $209 |
| Metoprolol Succinate | 11 | $168 |
| Amlodipine Besylate | 17 | $110 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $101 |
| Lisinopril | 20 | $74 |
| Metformin Hcl | 13 | $69 |
| Montelukast Sodium | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Point Pleasant
- Randall HawkinsPoint Pleasant$6K
- William ChapmanCharleston$1.7M
- David PickeringParkersburg$599K
- Govind PatelFairmont$59K
- Bisher MustafaHuntington$28K
- Johny AlencherryMartinsburg$27K
- Ali KhanBuckhannon$21K
- Joseph HashemBerkeley Springs$21K
- David PatickHuntington$18K
- Phillip TriplettCharleston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.